Similar Papers

Paper Title
Journal
Date
Author
ABC 1 (1st International consensus guidelines for advanced breast cancer): A positive step
Kathleen I Pritchard ... Berta Sousa
The Breast | VOL. 21
Kathleen I Pritchard, et. al.Kathleen I Pritchard ... Berta Sousa
01 Jun 2012
Docetaxel, cisplatin, UFT and leucovorin combination chemotherapy in advanced gastric cancer
S C Oh ... S Shin
Journal of Clinical Oncology | VOL. 22
S C Oh, et. al.S C Oh ... S Shin
15 Jul 2004
Docetaxel, cisplatin, UFT and leucovorin combination chemotherapy in advanced gastric cancer
S C Oh ... J H Seo
Journal of Clinical Oncology | VOL. 22
S C Oh, et. al.S C Oh ... J H Seo
15 Jul 2004
RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer.
Daisuke Fujimoto ... Kenji Koneri
Oncotarget | VOL. 9
Daisuke Fujimoto, et. al.Daisuke Fujimoto ... Kenji Koneri
08 Mar 2018
View more papers

More From: Journal of Clinical Oncology

Paper Title
Journal
Date
Author
Missed Opportunity for Sotorasib Dose Optimization
Garth W Strohbehn ... Mark J Ratain
Journal of Clinical Oncology | VOL. -
Garth W Strohbehn, et. al.Garth W Strohbehn ... Mark J Ratain
06 Feb 2025
Combination Immunotherapy With Nivolumab Plus Ipilimumab in Melanoma of Unknown Primary
Sapna P Patel ... Theresa Medina
Journal of Clinical Oncology | VOL. -
Sapna P Patel, et. al.Sapna P Patel ... Theresa Medina
06 Feb 2025
Rethinking the Path to Bladder Cancer Staging: Can Magnetic Resonance Imaging Speed Up Time to Receipt of Therapy in Patients With Muscle-Invasive Bladder Cancer?
Ashish M Kamat ... Paul Frankel
Journal of Clinical Oncology | VOL. -
Ashish M Kamat, et. al.Ashish M Kamat ... Paul Frankel
05 Feb 2025
Combined Analyses of Circulating Tumor DNA and Immunoscore in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the PRODIGE-GERCOR IDEA-France/HORG-IDEA-Greece Trials
Julien Taieb ... Pierre Laurent-Puig
Journal of Clinical Oncology | VOL. -
Julien Taieb, et. al.Julien Taieb ... Pierre Laurent-Puig
04 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.